Evaluation of some Hematological and Inflammatory Factors in Iraqi Patients Suffering from COVID-19 and Type 2 Diabetes Mellitus
DOI:
https://doi.org/10.23851/mjs.v34i3.1357Keywords:
COVID-19, T2DM, Lymphocytes, Neutrophils, CRP, D-dimer, FerritinAbstract
COVID-19 is a newly recognized sickness spreading rapidly worldwide and causing many consequences and deaths. Diabetes Mellitus(DM) is suggested as a risk factor that contributes to the severity and mortality of COVID-19. The present study investigates the levels of Lymphocytes, Neutrophils, C-reactive protein, D-dimer, and ferritin, in COVID-19 patients who suffer from type 2 diabetes mellitus (T2DM) and those without T2DM. 80 participants enrolled in this study, distributed into 4 groups; Group 1 (G1) included 20 patients with COVID-19 and T2DM; Group 2 (G2) comprised of 20 patients with COVID-19; Group 3(G3) included T2DM patients. In addition, 20 individuals were taken as a healthy control group. The patient samples were obtained from Ibn-AlKhateeb Hospital /Baghdad in the period between February to April 2022. A hematology automated device was utilized to count lymphocytes and neutrophils, while a biochemical automated device was employed to measure D-dimer, CRP, and ferritin. Regarding the blood immune cells, there was a significant decrease in lymphocyte counts and a significant increase in neutrophil counts in G1 and G2 groups compared to the healthy control group. The serum levels of the studying markers(CRP, D-dimer, and ferritin )were increased in the G1, G2, and G3 compared to the control group. Furthermore, patients in the G1 group had higher levels of these markers than in other groups, which are considered prognostic markers for COVID-19 infection.
Received: 24/03/2023
Revised: 07/05/2023
Accepted: 28/05/2023
Downloads
References
C. Huang,Y. Wang, X. Li, L. Ren, J. Zhao, Y.Hu, ... &B. Cao , ''Clinical features of patients infected with 2019 novel coronavirus in Wuhan ,China'', The lancet, 2020,pp.497-506..
E.Mahase,'' Covid-19:WHO declares pandemic because of "alarming levels "of spread, severity, and inaction'', Bmj,2020,m1036.
S.A. Meo, A.M. Alhowikan, T. Al-Khlaiwi, I. M .Meo, D. M .Halepoto ,M. Iqbal, ... &N. Ahmed, ''Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV'', Eur Rev Med PharmacolSci, ,2020, pp.2012-2019.
S. A. Abid ,S.N. Aziz., N. A .H .A.A. Saeed, S.N.Mizil , I. M. Al-Kadmy, N.H. Hussein, ... & J.D . Hussein, ''Investigation of Virulence Factors in Microbial Organisms that Associated with Public Health Risk Isolates from Different Environmental Regions''. Al-Mustansiriyah Journal of Science, 2022 ,pp. 1-7.
B .K. Tripathi, & A. K. Srivastava, ''Diabetes mellitus: complications and therapeutics ', MedSciMonit,2006, pp.130-47.
N. Zhu ,D .Zhang ,W.Wang, X.Li,B. Yang, J. Song,...& W. Tan, ''A novel coronavirus from patients with pneumonia in China,2019''.New England journal of medicine,2020.
Y. Fu, L.Hu, H.W, Ren, Y. Zuo, S.Chen, Q.S. Zhang, ... &Y. Deng, ''Prognostic factors for COVID-19 hospitalized patients with preexisting type 2 diabetes'', International Journal of Endocrinology, 2022.
H. Han, Z. Xu, X. Cheng, Y. Zhong, L.Yuan, F.Wang, ... &Y. Xia, ''Descriptive, retrospective study of the clinical characteristics of asymptomatic COVID-19 patients''. MSphere,2020,p.00922-20.
C. Rosales, ''Neutrophils at the crossroads of innate and adaptive immunity''. Journal of Leucocyte Biology, 2020,377-396.
S . Colafrancesco, C. Alessandri, F.Conti, &R. Priori, ''COVID-19 gone bad: A new character in the spectrum of the hyperferritinemia syndrome?''. Autoimmunity reviews, 2020,102573.
H. Asakura &H. Ogawa, ''COVID-19-associated coagulopathy and disseminated intravascular coagulation''. International Journal of Hematology,2020, pp.45-57.
H.Debi, Z.T. Itu, M .T .Amin, F. Hussain, &M. S. Hossain, ''Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis''. Expert Review of Endocrinology & Metabolism, 2022, pp. 83-93.
G. Ponti, M. Maccaferri,C.Ruini, A. Tomasi& T . Ozben,'' Biomarkers associated with COVID-19 disease progression'', Critical reviews in clinical laboratory sciences, 2020, pp.389-399.
K. Brennan, K. Martin, S.P. FitzGerald, J. O'Sullivan, Y. Wu, A.Blanco, ... &M.M. Mc Gee, ''A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum'', Scientific reports,2020,p.1039.
A. K . Abood, &L .K. Al-Joofy, ''Screening covid-19 in apparently healthy individuals'', International Journal of Drug Delivery Technology,2021, pp.846-849.
G. Chen, D.I. Wu, W . Guo, Y. Cao, D. Huang, H. Wang, ...& Q. Ning, ''Clinical and immunological features of severe and moderate coronavirus disease 2019''. The Journal of clinical investigation, 2020, pp.2620-2629.
Y. Cheng, L. Yue, Z.Wang, J. Zhang & G. Xiang, ''Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus''. Journal of Diabetes and its Complications,2021, p.107809.
A.Jafarzadeh, S.Jafarzadeh, P.Nozari, P.Mokhtari, &M. Nemati, ''Lymphopenia an important immunological abnormality in patients with COVID‐19: possible mechanisms''. Scandinavian Journal of Immunology,2021, p.12967.
C.Qin, L.Zhou,Z. Hu, S.Zhang, S. Yang, Y.Tao, ... &D.S.Tian, '' Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China''. Clinical infectious diseases,2020, pp.762-768.
Z. Wu, & J. M .McGoogan,'' Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention''. jama,2020, pp.1239-1242.
J. Schulte- Schrepping ,N. Reusch, D. Paclik, K. Baßler, S. Schlickeiser, B. Zhang, ... & J . Ziebuhr, ''Severe COVID-19 is marked by a dysregulated myeloid cell compartment'', Cell,2020, pp.1419-1440.
L .H .A .Cavalcante-Silva ,D.C.M. Carvalho, E.de Almeida Lima,J.G. Galvao, J.S.D.F. da Silva, J.M. de Sales-Neto, & S. Rodrigues-Mascarenhas, ''Neutrophils and COVID-19: The road so far''. International immunopharmacology, 2021, p.107233.
G.Y. Yitbarek, G. WalleAyehu, S . Asnakew, F. Y. Ayele, M. BarisoGare, A. T. Mulu, ...&B. D. Melesie, ''The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review''. SAGE Open Medicine, 2021, 20503121211050755.
L. A. Potempa, I.M. Rajab, P.C. Hart, J.Bordon, & R. Fernandez-Botran, ''Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections''. The American Journal of tropical medicine and hygiene,2020, 561.
D. Stringer, P. Braude, P.K. Myint, L. Evans, J.T. Collins, A. Verduri, ... & B. Carter, ''The role of C-reactive protein as a prognostic marker in COVID-19''. International journal of epidemiology,2021, pp.420-429.
D. Coster, A. Wasserman, E . Fisher, O . Rogowski, D. Zeltser, I. Shapira, ... &R . Shamir,'' Using the kinetics of C-reactive protein response to improve the differential diagnosis between acute bacterial and viral infections''. Infection, 2020, pp.241-248.
F.Liu, L.Li, M. Xu, J. Wu,D. Luo, Y. Zhu, ... &X.Zhou, ''Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19''. Journal of clinical virology, 2020, 104370.
S.A. AlMeani, A. H. Abdulkareem, M.O. Ibrahim, M.M.Ahmed, &M.Y . Mukhlif,'' Assessment the correlation of D-dimer and ferritin level in patients infected with Covid-19 in Anbar Governorate of Iraq''. Syst. Rev. Pharm,2020, pp.1130-1133.
Y. Mishra, B.K. Pathak, S. S. Mohakuda, T.V.S.V. G. K. Tilak, S. Sen, P. Harikrishnan, ... &A . R .Singh, ''Relation of D-dimer levels of COVID-19 patients with diabetes mellitus''. Diabetes & Metabolic Syndrome: Clinical Research & Reviews,2020, pp.1927-1930.
Z. F. Long, G.Y. Qu, &M.Xu, ''Relationship between the level of plasma D-dimer and diabetic microangiopathy''. Hunan yike da xuexuebao= Hunan YikeDaxueXuebao= Bulletin of Hunan Medical University,2001, pp.434-436.
C. Wu, X.Chen, Y. Cai, X.Zhou, S.Xu, H.Huang, ... &Y. Song, ''Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China''. JAMA internal medicine,2020, pp.934-943.
A.N. Kaftan, M . K .Hussain, A.A . Algenabi, F.H. Naser,& M.A . Enaya, ''Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin, and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study''. Acta Informatica Medica,2021.
A.N. Kaftan, M. K . Hussain, A.A. Algenabi, F.H. Naser,&M. A.Enaya, ''Predictive Value of C-reactive Protein, Lactate Dehydrogenase, Ferritin, and D-dimer Levels in Diagnosing COVID-19 Patients: a Retrospective Study''. Acta Informatica Medica,2021.
K. Kaushal, H. Kaur, P. Sarma, A. Bhattacharyya, D.J. Sharma, M.Prajapat, ...&M. Naithani, ''Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis, and meta-regression analysis''. Journal of Critical Care,2022, pp.172-181.
Downloads
Key Dates
Published
Issue
Section
License
Copyright (c) 2023 Al-Mustansiriyah Journal of Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles accepted for publication in Al-Mustansiriyah Journal of Science (MJS) are protected under the Creative Commons Attribution 4.0 International License (CC BY-NC). Authors of accepted articles are requested to sign a copyright release form prior to their article being published. All authors must agree to the submission, sign copyright release forms, and agree to be included in any correspondence between MJS and the authors before submitting a work to MJS. For personal or educational use, permission is given without charge to print or create digital copies of all or portions of a MJS article. However, copies must not be produced or distributed for monetary gain. It is necessary to respect the copyright of any parts of this work that are not owned by MJS.
How to Cite
